Abstract
To replicate, viruses must form stable particles that are released from infected cells, yet must disassemble and release their genomes following entry into target cells. Retroviruses, including the human immunodeficiency viruses HIV-1 and HIV-2, resolve this conundrum through assembly of particles from polyproteins followed by maturation of the core via proteolytic cleavage of the polyproteins. Cleavage of the Gag and Gag–Pol polyproteins results in morphogenesis of the core containing a metastable capsid that is competent for disassembly upon penetration of a cell. For HIV-1, inhibition of the viral protease results in immature particles that are impaired at entry as well as post-entry stages of infection. Hence, drugs targeting the viral protease represent a major arm of current therapy for HIV infection. In this chapter, we review the current state of knowledge regarding HIV-1 maturation, including structural and mechanistic aspects as well as the consequences of its inhibition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weiss ER, Gottlinger H (2011) The role of cellular factors in promoting HIV budding. J Mol Biol 410(4):525–533
Pettit SC, Everitt LE, Choudhury S, Dunn BM, Kaplan AH (2004) Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. J Virol 78(16):8477–8485
Lee SK, Potempa M, Kolli M, Ozen A, Schiffer CA, Swanstrom R (2012) Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease. J Biol Chem 287(16):13279–13290
Tritch RJ, Cheng Y-SE, Yin FH, Erickson-Viitanen S (1991) Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J Virol 65(2):922–930
Krausslich HG, Ingraham RH, Skoog MT, Wimmer E, Pallai PV, Carter CA (1989) Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc Natl Acad Sci USA 86(3):807–811
Pettit SC, Moody MD, Wehbie RS, Kaplan AH, Nantermet PV, Klein CA et al (1994) The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol 68(12):8017–8027
Lee SK, Harris J, Swanstrom R (2009) A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle. J Virol 83(17):8536–8543
Forshey BM, von Schwedler U, Sundquist WI, Aiken C (2002) Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76(11):5667–5677
von Schwedler UK, Stray KM, Garrus JE, Sundquist WI (2003) Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 77(9):5439–5450
Byeon IJ, Meng X, Jung J, Zhao G, Yang R, Ahn J et al (2009) Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 139(4):780–790
Tang S, Murakami T, Agresta BE, Campbell S, Freed EO, Levin JG (2001) Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J Virol 75(19):9357–9366
Jiang J, Ablan SD, Derebail S, Hercik K, Soheilian F, Thomas JA et al (2011) The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability. Virology 421(2):253–265
Tang S, Ablan S, Dueck M, Ayala-Lopez W, Soto B, Caplan M et al (2007) A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein. Virology 359(1):105–115
Yang R, Aiken C (2007) A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. J Virol 81(8):3749–3756
Yang R, Shi J, Byeon I-JL, Ahn J, Sheehan JH, Meiler J et al (2012) Identification of second-site suppressors of human immunodeficiency virus type 1 CA mutants: restoration of intracellular activities without correction of intrinsic capsid stability defects. Retrovirology 9:30
Huber HE, McCoy JM, Seehra JS, Richardson CC (1989) Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching. J Biol Chem 264(8):4669–4678
Bebenek K, Abbotts J, Roberts JD, Wilson SH, Kunkel TA (1989) Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J Biol Chem 264(28):16948–16956
Blair WS, Pickford C, Irving SL, Brown DG, Anderson M, Bazin R et al (2010) HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog 6(12):e1001220
Kortagere S, Madani N, Mankowski MK, Schon A, Zentner I, Swaminathan G et al (2012) Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid. J Virol 86(16):8472–8481
Shi J, Zhou J, Shah VB, Aiken C, Whitby K (2011) Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. J Virol 85(1):542–549
Briggs JA, Grunewald K, Glass B, Forster F, Krausslich HG, Fuller SD (2006) The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure 14(1):15–20
Hoglund S, Ofverstedt LG, Nilsson A, Lundquist P, Gelderblom H, Ozel M et al (1992) Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res Hum Retroviruses 8(1):1–7
Wright ER, Schooler JB, Ding HJ, Kieffer C, Fillmore C, Sundquist WI et al (2007) Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J 26(8):2218–2226
Briggs JA, Riches JD, Glass B, Bartonova V, Zanetti G, Krausslich HG (2009) Structure and assembly of immature HIV. Proc Natl Acad Sci USA 106(27):11090–11095
Yeager M (2011) Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assembly. J Mol Biol 410(4):534–552
Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD et al (2009) X-ray structures of the hexameric building block of the HIV capsid. Cell 137(7):1282–1292
Pornillos O, Ganser-Pornillos BK, Yeager M (2011) Atomic-level modelling of the HIV capsid. Nature 469(7330):424–427
Li S, Hill CP, Sundquist WI, Finch JT (2000) Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409–413
Meng X, Zhao G, Yufenyuy E, Ke D, Ning J, Delucia M et al (2012) Protease cleavage leads to formation of mature trimer interface in HIV-1 capsid. PLoS Pathog 8(8):e1002886
de Marco A, Muller B, Glass B, Riches JD, Krausslich HG, Briggs JA (2010) Structural analysis of HIV-1 maturation using cryo-electron tomography. PLoS Pathog 6(11):e1001215
Keller PW, Adamson CS, Heymann JB, Freed EO, Steven AC (2011) HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice. J Virol 85(4):1420–1428
Zhou J, Yuan X, Dismuke D, Forshey BM, Lundquist C, Lee KH et al (2004) Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J Virol 78(2):922–929
Wiegers K, Rutter G, Kottler H, Tessmer U, Hohenberg H, Krausslich H-G (1998) Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol 72(4):2846–2854
von Schwedler UK, Stemmler TL, Sundquist WI (1998) Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J 17:1555
Gross I, Hohenberg H, Huckhagel C, Krausslich H-G (1998) N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol 72:4798–4810
Wildova M, Hadravova R, Stokrova J, Krizova I, Ruml T, Hunter E et al (2008) The effect of point mutations within the N-terminal domain of Mason-Pfizer monkey virus capsid protein on virus core assembly and infectivity. Virology 380(1):157–163
Cortines JR, Monroe EB, Kang S, Prevelige PE Jr (2011) A retroviral chimeric capsid protein reveals the role of the N-terminal beta-hairpin in mature core assembly. J Mol Biol 410(4):641–652
Tang C, Ndassa Y, Summers MF (2002) Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol 9(7):537–543
Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI (2004) Assembly properties of the human immunodeficiency virus type 1 CA protein. J Virol 78(5):2545–2552
Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, Taylor IA (2004) High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431(7007):481–485
Mayo K, Huseby D, McDermott J, Arvidson B, Finlay L, Barklis E (2003) Retrovirus capsid protein assembly arrangements. J Mol Biol 325(1):225–237
Bharat TA, Davey NE, Ulbrich P, Riches JD, de Marco A, Rumlova M et al (2012) Structure of the immature retroviral capsid at 8 Ǻ resolution by cryo-electron microscopy. Nature 487(7407):385–389
Accola MA, Hoglund S, Gottlinger HG (1998) A putative a-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J Virol 72(3):2072–2078
Liang C, Hu J, Russell RS, Roldan A, Kleiman L, Wainberg MA (2002) Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag. J Virol 76(22):11729–11737
Morellet N, Druillennec S, Lenoir C, Bouaziz S, Roques BP (2005) Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging. Protein Sci 14(2):375–386
Datta SA, Temeselew LG, Crist RM, Soheilian F, Kamata A, Mirro J et al (2011) On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? J Virol 85(9):4111–4121
Pettit SC, Henderson GJ, Schiffer CA, Swanstrom R (2002) Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease. J Virol 76(20):10226–10233
Canady MA, Tihova M, Hanzlik TN, Johnson JE, Yeager M (2000) Large conformational changes in the maturation of a simple RNA virus, nudaurelia capensis omega virus (NomegaV). J Mol Biol 299(3):573–584
Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, Chipman PR et al (2008) Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319(5871):1834–1837
Conway JF, Wikoff WR, Cheng N, Duda RL, Hendrix RW, Johnson JE et al (2001) Virus maturation involving large subunit rotations and local refolding. Science 292(5517):744–748
Briggs JA, Simon MN, Gross I, Krausslich HG, Fuller SD, Vogt VM et al (2004) The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 11(7):672–675
Lanman J, Lam TT, Emmett MR, Marshall AG, Sakalian M, Prevelige PE Jr (2004) Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat Struct Mol Biol 11(7):676–677
Ma YM, Vogt VM (2002) Rous sarcoma virus Gag protein-oligonucleotide interaction suggests a critical role for protein dimer formation in assembly. J Virol 76(11):5452–5462
Fu W, Gorelick RJ, Rein A (1994) Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol 68(8):5013–5018
Shehu-Xhilaga M, Kraeusslich HG, Pettit S, Swanstrom R, Lee JY, Marshall JA et al (2001) Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J Virol 75(19):9156–9164
Rein A (2010) Nucleic acid chaperone activity of retroviral Gag proteins. RNA Biol 7(6):700–705
Cen S, Khorchid A, Gabor J, Rong L, Wainberg MA, Kleiman L (2000) Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1. J Virol 74(22):10796–10800
Hunter E, Swanstrom R (1990) Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 157:187–253
Cosson P (1996) Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 15(21):5783–5788
Murakami T, Freed EO (2000) Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J Virol 74(8):3548–3554
Freed EO, Martin MA (1996) Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation. J Virol 70:341–351
Murakami T, Freed EO (2000) The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Natl Acad Sci USA 97(1):343–348
Wyma DJ, Kotov A, Aiken C (2000) Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J Virol 74(20):9381–9387
Murakami T, Ablan S, Freed EO, Tanaka Y (2004) Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J Virol 78(2):1026–1031
Wyma DJ, Jiang J, Shi J, Zhou J, Lineberger JE, Miller MD et al (2004) Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J Virol 78(7):3429–3435
Kol N, Shi Y, Tsvitov M, Barlam D, Shneck RZ, Kay MS et al (2007) A stiffness switch in human immunodeficiency virus. Biophys J 92(5):1777–1783
Joyner AS, Willis JR, Crowe JE Jr, Aiken C (2011) Maturation-induced cloaking of neutralization epitopes on HIV-1 particles. PLoS Pathog 7(9):e1002234
Chojnacki J, Staudt T, Glass B, Bingen P, Engelhardt J, Anders M et al (2012) Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. Science 338(6106):524–528
Li F, Goila-Gaur R, Salzwedel K, Kilgore NR, Reddick M, Matallana C et al (2003) PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc Natl Acad Sci USA 100(23):13555–13560
Adamson CS, Sakalian M, Salzwedel K, Freed EO (2010) Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat. Retrovirology 7:36
Adamson CS, Ablan SD, Boeras I, Goila-Gaur R, Soheilian F, Nagashima K et al (2006) In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat). J Virol 80(22):10957–10971
Nguyen AT, Feasley CL, Jackson KW, Nitz TJ, Salzwedel K, Air GM et al (2011) The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles. Retrovirology 8:101
Blair WS, Cao J, Fok-Seang J, Griffin P, Isaacson J, Jackson RL et al (2009) New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation. Antimicrob Agents Chemother 53(12):5080–5087
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Aiken, C., Zhang, P. (2013). HIV-1 Maturation. In: Freed, E. (eds) Advances in HIV-1 Assembly and Release. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7729-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7729-7_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7728-0
Online ISBN: 978-1-4614-7729-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)